Fundraising Fox

Svenja Harms

Investor

Partner at DROIA VENTURES at Droia Ventures · Principal at Crowberry Capital

Reykjavík, Capital Region, Iceland

Find your path to Svenja

66 people in our graph share verified history with Svenja — schools, employers, funds. One of them is your warm intro.

Robert VerwaayenunlockedSvenja: together at Lucinity (2023)
Svenja: together at Lucinity
×3Svenja: together at Droia Ventures
×2Svenja: together at zeb consulting

About

Svenja Harms is a Partner at DROIA Ventures whose expertise includes biotechnology corporate development transactions such as in-licensing, out-licensing, and M&A, as well as corporate strategy and the development of CNS, oncology, and inflammation therapeutics. She currently serves as a Director at MorphoSys AG and Sage Therapeutics and as Chair of Carrick Therapeutics and Shattuck Labs.

Contact· self-published, not guessed

Experience

  1. Crowberry CapitalPrincipalcurrent2025 — presentReykjavik, Capital Region, Iceland
  2. Harms Schaltanlagen GmbHMember of the Management Boardcurrent2023 — presentOldenburg, Niedersachsen, Deutschland
  3. LucinityData Scientist2023Reykjavik, Höfuðborgarsvæðið, Island
  4. Crowberry CapitalData Scientist2022 — 2023Reykjavik, Höfuðborgarsvæðið, Island
  5. Technische Universität BraunschweigResearch And Teaching Assistant2020 — 2021Braunschweig, Niedersachsen, Deutschland
  6. zeb consultingStudent Assistant Data Management2020
  7. Verband Deutscher Studierendeninitiativen e. V. (VDSI e. V.)National Board Member2017 — 2018
  8. bonding studenteninitiative e.V.Local President2016 — 2017Braunschweig und Umgebung, Deutschland

Skills & more

Leitung von Ehrenamtlichen1Youth LeadershipProjektmanagement1DatenvisualisierungBusiness-AnalyseDatenmodellierungTutoringPräsentationenApplied mathematicsUnternehmensberatungMatlabMicrosoft Office
+5 morePythonCSQLMathematical optimizationTeamwork

Languages Deutsch · English · Isländisch

  • Train the Trainerbonding-studierendeninitiative e. V.

From Svenja's professional profile.

Colleagues at Droia Ventures

Frequently asked questions

Who is Svenja Harms?
Svenja Harms is a Partner at DROIA Ventures whose expertise includes biotechnology corporate development transactions such as in-licensing, out-licensing, and M&A, as well as corporate strategy and the development of CNS, oncology, and inflammation therapeutics. She currently serves as a Director at MorphoSys AG and Sage Therapeutics and as Chair of Carrick Therapeutics and Shattuck Labs.
Where does Svenja Harms work?
Svenja Harms is Partner at DROIA VENTURES at Droia Ventures.
Where did Svenja Harms go to school?
Svenja Harms studied at Technische Universität Braunschweig (Master of Science - MS, Mathematics); Háskóli Íslands (Master of Science - MS, Mathematics); Technische Universität Braunschweig (Bachelor of Applied Science - BASc, Mathematics in Finance and Industry).

Same school

Shared employers